Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
23.44
-0.50 (-2.09%)
At close: Aug 15, 2025, 3:59 PM
23.33
-0.47%
After-hours: Aug 15, 2025, 04:34 PM EDT
Inhibrx Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -134.26M | 1.72B | 1.69B | 1.64B | 1.6B | -271.15M | -241.36M | -188.67M | -172.21M | -162.89M | -145.23M | -125.5M | -110.75M | -93.73M | -81.77M | -78.23M | -78.14M | -75.32M |
Depreciation & Amortization | 2.79M | 2.6M | 2.29M | 1.89M | 1.44M | 1.26M | 1.19M | 1.2M | 1.2M | 1.21M | 1.23M | 1.23M | 1.22M | 1.21M | 1.2M | 1.15M | 1.1M | 1.05M |
Stock-Based Compensation | 11.17M | 55.92M | 59.87M | 63.32M | 66.88M | 25.61M | 23.9M | 22.83M | 20.99M | 20.03M | 20.45M | 19.28M | 18.08M | 16.73M | 15.05M | 12.24M | 10.05M | 7.36M |
Other Working Capital | 15.44M | 33.51M | 33.79M | 57.27M | 47.6M | 29.5M | 24.89M | 1.96M | 1.06M | 582K | 694K | -3M | -2.5M | -2.8M | -1.67M | -2.47M | -2.23M | -4.35M |
Other Non-Cash Items | 19.81M | -1.94B | -1.94B | -1.94B | -1.96B | 11.31M | 11.23M | 6.64M | 6.4M | 5.8M | 5.08M | 4.19M | 3.53M | 3.07M | 2.73M | 2.44M | 6.23M | 10.25M |
Deferred Income Tax | n/a | n/a | n/a | -4.56M | -4.56M | -4.56M | -4.56M | 1K | n/a | n/a | n/a | n/a | n/a | -9K | -9K | -9K | 502K | -2.18M |
Change in Working Capital | -39.36M | -3.87M | 4K | 28.36M | 60.07M | 21.13M | 15.35M | -10.03M | -1M | 6.58M | 3.16M | -6.53M | -2.23M | -12.89M | -17.52M | -10.68M | -13.04M | -3.39M |
Operating Cash Flow | -139.85M | -167.25M | -194.41M | -207.51M | -231.47M | -216.41M | -193.31M | -167.09M | -143.68M | -128.3M | -115.3M | -107.32M | -90.16M | -85.62M | -80.32M | -73.09M | -73.3M | -62.23M |
Capital Expenditures | -284K | -1.5M | -2.6M | -6.02M | -6.59M | -5.69M | -4.59M | -1.42M | -587K | -592K | -686K | -686K | -875K | -967K | -864K | -1.21M | -1.34M | -1.29M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55K | 55K | 55K | 55K | n/a |
Investing Cash Flow | -284K | -1.5M | -2.6M | -6.02M | -6.59M | -5.69M | -4.59M | -1.42M | -587K | -592K | -686K | -686K | -875K | -912K | -809K | -1.15M | -1.28M | -1.29M |
Debt Repayment | 99.97M | 99.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 35.53M | 35.53M | 35.66M | 3.56M | 200.75M | 201.6M | 201.96M | 359.76M | 160.38M | 219.68M | 258.55M | 141.38M | 141.69M | 122M | 83.77M | 59.28M | 194.68M | 171.08M |
Financial Cash Flow | 102.55M | 135.5M | 74.38M | 75.24M | 272.43M | 240.33M | 201.96M | 359.76M | 160.38M | 219.68M | 258.55M | 141.38M | 141.69M | 122M | 83.77M | 59.28M | 194.68M | 171.08M |
Net Cash Flow | -40.29M | -35.96M | -125.33M | -141M | 34.37M | 18.23M | 4.06M | 191.25M | 16.11M | 90.79M | 142.56M | 33.37M | 50.66M | 35.48M | 2.64M | -14.96M | 120.1M | 107.56M |
Free Cash Flow | -140.13M | -168.75M | -197.01M | -213.53M | -238.06M | -222.1M | -197.9M | -168.51M | -144.27M | -128.9M | -115.99M | -108.01M | -91.03M | -86.58M | -81.19M | -74.3M | -74.64M | -63.52M |